Nautilus Biotechnology, Inc. (NAUT) Earnings Per Share (EPS)
Nautilus Biotechnology, Inc. (NAUT) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2018-12-31 | $0.49 |
| 2019-12-31 | -$3.13 |
| 2020-12-31 | -$0.54 |
| 2021-12-31 | -$0.60 |
| 2022-03-31 | -$0.72 |
| 2022-12-31 | -$0.46 |
| 2023-03-31 | -$3.34 |
| 2023-12-31 | -$0.51 |
| 2024-12-31 | -$0.56 |
| 2025-12-31 | -$0.47 |
How NAUT compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ACRS | Aclaris Therapeutics Inc. | -$0.53 |
| CRVS | Corvus Pharmaceuticals Inc. | -$0.53 |
| AVXL | Anavex Life Sciences Corp. | -$0.54 |
| ALDX | Aldeyra Therapeutics Inc. | -$0.56 |
| STIM | Neuronetics Inc. | -$0.59 |
These are five companies in the same sector as NAUT with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Nautilus Biotechnology, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("NAUT")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NAUT | $0.89 | +0.22% | 0.63M |
| 3 | ||||
| 4 | ||||
| 5 |